Published on August 10, 2016
Decision applauded by the Prevent Cancer Foundation
Alexandria, VA— August 10, 2016 — New guidelines published by the National Comprehensive Cancer Network (NCCN) recommend that physicians consider breast tomosynthesis exams as an option for their patients’ annual breast cancer screening. The Prevent Cancer Foundation applauds this move to recognize breast tomosynthesis (often called 3D mammograms) as a valid option for annual breast cancer screening.
The past few years have brought a lot of confusion for patients and referring physicians on the best option for screening mammography. This recommendation from NCCN will assist in bringing breast tomosynthesis exams forward as a trusted screening option that can improve cancer detection and decrease call-back rates. Digital tomosynthesis is especially beneficial for women with dense breasts and those who have had breast augmentation
NCCN’s recommendation will also increase the number of insurance companies that provide full coverage for this type of exam, since many insurance companies reference NCCN guidelines in their coverage policies.
The NCCN Guidelines, published in “NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis,” are developed and updated by an impartial, physician-led group of clinicians and oncology researchers.
About the Prevent Cancer Foundation
The Prevent Cancer Foundation is one of the nation’s leading voluntary health organizations and the only U.S. nonprofit focused solely on cancer prevention and early detection. Founded in 1985, it has catapulted cancer prevention to prominence and fulfills its mission through research, education, outreach and advocacy across the country.
For more information, please visit www.preventcancer.org.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
